Literature DB >> 21717278

Evaluation of plumbagin and its derivative as potential modulators of redox thiol metabolism of Leishmania parasite.

Neha Sharma1, Anil Kumar Shukla, Mousumi Das, Vikash Kumar Dubey.   

Abstract

Trypanothione and trypanothione reductase (TryR)-based redox metabolism found in Leishmania and other trypanosomatids exemplify the unique features of this group of organisms. Its absence in mammalian hosts, together with the sensitivity of trypanosomes against oxidative stress, makes this enzyme a unique target for exploitation for potential antileishmanial chemotherapeutics. Plumbagin, a plant-derived naphthoquinone, is reported to possess antileishmanial properties by inhibiting TryR. We here report the kinetics of the inhibitory mechanism of plumbagin and its derivative, 2-methoxy 1, 4-naphthoquinone. Interestingly, apart from acting as inhibitor, these compounds also act as subversive substrates and subvert the physiological function of enzyme by converting it from an antioxidant to a prooxidant. Both naphthoquinones show a significant effect on redox homeostasis and results in increased reactive oxygen species, resulting in morphological changes and parasite death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717278     DOI: 10.1007/s00436-011-2498-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  16 in total

1.  Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis.

Authors:  Paola Baiocco; Stefano Franceschini; Andrea Ilari; Gianni Colotti
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

2.  Modeled structure of trypanothione reductase of Leishmania infantum.

Authors:  Bishal K Singh; Nandini Sarkar; M V Jagannadham; Vikash K Dubey
Journal:  BMB Rep       Date:  2008-06-30       Impact factor: 4.778

3.  In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism.

Authors:  J R Luque-Ortega; O M Rivero-Lezcano; S L Croft; L Rivas
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  In vitro leishmanicidal activity of monomeric and dimeric naphthoquinones.

Authors:  O Kayser; A F Kiderlen; H Laatsch; S L Croft
Journal:  Acta Trop       Date:  2000-12-01       Impact factor: 3.112

5.  Synthesis of plumbagin derivatives and their inhibitory activities against Ehrlich ascites carcinoma in vivo and Leishmania donovani Promastigotes in vitro.

Authors:  Banasri Hazra; Rajes Sarkar; Saswati Bhattacharyya; Prabir K Ghosh; Gautam Chel; Biswanath Dinda
Journal:  Phytother Res       Date:  2002-03       Impact factor: 5.878

6.  Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi.

Authors:  L Salmon-Chemin; A Lemaire; S De Freitas; B Deprez; C Sergheraert; E Davioud-Charvet
Journal:  Bioorg Med Chem Lett       Date:  2000-04-03       Impact factor: 2.823

7.  Human leishmaniases: epidemiology and public health aspects.

Authors:  P Desjeux
Journal:  World Health Stat Q       Date:  1992

Review 8.  Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism.

Authors:  R Luise Krauth-Siegel; Marcelo A Comini
Journal:  Biochim Biophys Acta       Date:  2008-03-18

9.  Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications.

Authors:  M Balasubramanyam; A Adaikala Koteswari; R Sampath Kumar; S Finny Monickaraj; J Uma Maheswari; V Mohan
Journal:  J Biosci       Date:  2003-12       Impact factor: 2.795

10.  In vitro antileishmanial effects of antibacterial diterpenes from two Ethiopian Premna species: P. schimperi and P. oligotricha.

Authors:  Solomon Habtemariam
Journal:  BMC Pharmacol       Date:  2003-06-06
View more
  4 in total

1.  Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate.

Authors:  Luiz Filipe Gonçalves Oliveira; Franklin Souza-Silva; Léa Cysne-Finkelstein; Kíssila Rabelo; Juliana Fernandes Amorim; Adriana de Souza Azevedo; Saulo Cabral Bourguignon; Vitor Francisco Ferreira; Marciano Viana Paes; Carlos Roberto Alves
Journal:  Biomed Res Int       Date:  2017-07-17       Impact factor: 3.411

2.  The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.

Authors:  Luiz Filipe Gonçalves-Oliveira; Franklin Souza-Silva; Luzia Monteiro de Castro Côrtes; Laura Barral Veloso; Bernardo Acácio Santini Pereira; Lea Cysne-Finkelstein; Guilherme Curty Lechuga; Saulo Cabral Bourguignon; Fernando Almeida-Souza; Kátia da Silva Calabrese; Vitor Francisco Ferreira; Carlos Roberto Alves
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-08-12       Impact factor: 4.077

Review 3.  Use of Natural Products in Leishmaniasis Chemotherapy: An Overview.

Authors:  Luiza F O Gervazoni; Gabrielle B Barcellos; Taiana Ferreira-Paes; Elmo E Almeida-Amaral
Journal:  Front Chem       Date:  2020-11-23       Impact factor: 5.221

4.  Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis.

Authors:  Si-Ming Zhang; Kristen A Coultas
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-12       Impact factor: 4.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.